Stock Earnings

Question 1

How did LCTX's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Lineage Cell Therapeutics Inc is $-0.13, beating expectations of $-0.02.

Question 2

How did Lineage Cell Therapeutics Inc LCTX's revenue perform in the last quarter?

Accepted Answer

Lineage Cell Therapeutics Inc revenue for the last quarter is $-0.13

Question 3

What is the revenue estimate for Lineage Cell Therapeutics Inc?

Accepted Answer

According to 9 of Wall street analyst, the revenue estimate of Lineage Cell Therapeutics Inc range from $3.57M to $375.34K

Question 4

What's the earning quality score for Lineage Cell Therapeutics Inc?

Accepted Answer

Lineage Cell Therapeutics Inc has a earning quality score of B+/49.934326. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Lineage Cell Therapeutics Inc report earnings?

Accepted Answer

Lineage Cell Therapeutics Inc next earnings report is expected in 2026-02-04

Question 6

What are Lineage Cell Therapeutics Inc's expected earnings?

Accepted Answer

Lineage Cell Therapeutics Inc expected earnings is $2.34M, according to wall-street analysts.

Question 7

Did Lineage Cell Therapeutics Inc beat earnings expectations?

Accepted Answer

Lineage Cell Therapeutics Inc recent earnings of $3.68M beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$-0.02	$-0.13	+550.0%	BEAT
Q2 '25	$-0.02	$-0.07	+250.0%	BEAT
Q1 '25	$-0.02	$-0.02	--	--
Q4 '24	$-0.0	$-0.01	--	--
Q3 '24	$-0.04	$-0.02	-50.0%	MISSED

Lineage Cell Therapeutics Inc (LCTX) Price

LCTX Stock Price Chart

Latest Earnings Results: Q3 '25

Historical Earnings

Earnings FAQ